DND Technologies, Inc. (DNDT) Research

Headquartered in New York City, DND Technologies, Inc. was established in 1997. Operating as a holding company, DND Technologies specializes in the production and sale of diverse specialty balms. Beyond balms, the company is a key manufacturer and distributor of pharmaceutical goods. Its portfolio includes Bioassaygen Gel, formulated to diminish wrinkles and promote natural skin regeneration. The Bioassaygen Cosmetic Mask serves aesthetic enhancement purposes. Additionally, DND offers Bioassaygen Bio-Skin, an innovative skin replacement bandage, and Bioassaygen Delivery Gel, designed to accelerate natural skin renewal. These products reach consumers and businesses through a multi-channel distribution strategy, encompassing wholesale, retail outlets, and e-commerce platforms.

Market snapshot

Symbol
DNDT
Price
$0.06
Day change
0.00%
Market cap
$184.3K
P/E ratio
-36.22x
52-week range
0.044-0.2
Sector
Consumer Defensive
Industry
Beverages - Non-Alcoholic

Peer companies

  • Ayujoy Herbals Ltd. (AJOY)
  • Accredited Solutions, Inc. (ASII)
  • DNA Brands, Inc. (DNAX)
  • Fernhill Beverage, Inc. (FHBC)
  • Hall of Fame Beverages, Inc. (HFBG)
  • M Line Holdings, Inc. (MLHC)
  • Nova Tech Enterprises, Inc. (NTEI)
  • Sun Tzu Corporation (STZU)

Recent insider activity

  • GIFFHORN LOWELL — trade (150000 shares) on 2003-08-11

Open DND Technologies, Inc. (DNDT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.